Telangana DCA officials seize mislabeled medicines
Officials from the Drugs Control Administration (DCA) of Telangana have detected certain medicines circulating in the market with misleading claims on their labels, stating that they treat 'Kidney Stones' and ‘Rheumatism’.
Hyderabad: Officials from the Drugs Control Administration (DCA) of Telangana have detected certain medicines circulating in the market with misleading claims on their labels, stating that they treat ‘Kidney Stones’ and ‘Rheumatism’.
These claims violate the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
The Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954 prohibits the advertisement of certain drugs for the treatment of specified diseases and disorders. According to the Act, no person shall participate in the publication of advertisements regarding the diseases or disorders listed.
During a special drive conducted on May 25 to identify medicines with misleading and objectionable advertisements, DCA officials detected the following products:
StoneLock Syrup, an Ayurvedic medicine manufactured by Lewib Healthcare, Plot No. 91, HSIIDC, Alipur, Barwala, Panchkula, Haryana, was found to have a misleading label claiming it treats ‘Kidney Stones’. Stocks of this medicine were seized during a raid at a medical shop in Jagtial by Drugs Inspector V. Upender.
Rheuam Liniment, an Ayurvedic medicine manufactured by Maheshwari Pharmaceuticals (I) Ltd., Plot No. 7, Sector 6 B, I.I.E, Haridwar, Uttarakhand, was found to have a misleading label claiming it treats ‘Rheumatism’. Stocks of this medicine were seized during a raid at a medical shop in Adilabad by Drugs Inspector A. Srilatha.
Advertising medicines for the treatment of ‘Kidney Stones and ‘Rheumatism’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Further investigation will be conducted, and action will be taken according to the law against all offenders. Individuals making misleading advertisements regarding drugs for the treatment of certain diseases and disorders are punishable under the Act, with imprisonment that may extend to six months, a fine, or both, a statement here said on Sunday.
